Screening for the prevention of cervical cancer in the era of human papillomavirus vaccination: An australian perspective

Acta Cytologica

Volumn 55, Issue 4, 2011, Pages 307-312

  Farnsworth, Annabelle ^a  

^a DOUGLASS HANLY MOIR PATHOLOGY   (Australia)

Author keywords

Cervical screening; Human papillomavirus vaccination; Pap smears; Pap test registers; Positive predictive value; Sensitivity

Indexed keywords

WART VIRUS VACCINE;

AUSTRALIA; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER SCREENING; PAPANICOLAOU TEST; PREDICTIVE VALUE; PRIORITY JOURNAL; REVIEW; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; VACCINATION; FEMALE; HUMAN; MASS SCREENING; ORGANIZATION AND MANAGEMENT; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; PATHOLOGY; UTERINE CERVIX TUMOR; VIROLOGY;

HUMAN PAPILLOMAVIRUS;

AUSTRALIA; FEMALE; HUMANS; MASS SCREENING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; UTERINE CERVICAL NEOPLASMS;

EID: 80052873898     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000326956     Document Type: Review

References (26)

1. Australasian Association of Cancer Registries, Australian Government: Australian Institute of Health and Welfare, Canberra, 2010. http://www.aihw.gov. au/cancer/data/ acim-books/cervical-cancer.xls .
2. Schiffman M: Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing. Cancer Cytopathol 2007; 111: 145-153.
3. Heideman D, Snijders PJ, Berkhof J, Verheijen RH, Helmerhorst TJ, Meijer CJ: Vaccination against HPV: indications for women and the impact on the cervical screening programme. BJOG 2008; 115: 938-946.
4. Goldhaber-Fiebert JD, Stout NK, Salomon JA, Kuntz KM, Goldie SJ: Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16, 18 vaccinations. J Natl Cancer Inst 2008; 100: 308-320.
5. Solomon D, Papillo JL, Davey DD: Statement on HPV DNA test utilization. Acta Cytol 2009; 53: 247-248.
6. National Pathology Accreditation Advisory Council: Requirements for Gynaecological (Cervical) Cytology. Canberra, ACT, 2006.
7. Shield PW, Finnimore J, Cummings M, Wright RG: Performance measures for Australian laboratories reporting cervical cytology: a decade of data 1998-2008. Pathology 2010; 42: 623-628.
8. National HPV Vaccination Program Register 2001, Victorian Cytology Service Inc, East Melbourne. http://www.hpvregister.org.au .
9. Garland S, Brotherton J, Stevens M, Tabrizi S, Condon J, McIntyre P, Smith D: The results of the WHINURS study (Women HPV Indigenous Non-Indigenous Urban Rural Study): a baseline genotype prevalence prior to vaccine rollout (abstract). Australian and New Zealand Vulvovaginal Society, November 2010.
10. Stevens MP, Garland SM, Tan JH, Quinn MA, Petersen RW, Tabrizi SN: HPV genotype prevalence in women with abnormal pap smears in Melbourne, Australia. J Med Virol 2009; 81: 1283-1291.
11. Smith MA, Canfell K, Brotherton JM, Lew JB, Barnabas RV: The predicted impact of vaccination on human papillomavirus infections in Australia. Int J Cancer 2008; 123: 1854-1863.
12. Donovan B, Franklin N, Grulich A.E, Regan D.G., Ali H., Wand H, Fairley CK, Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data, Lancet. Infect. Dis., 2011, 11, 39-44
13. Farnsworth A: The changing landscape for cervical screening. Med J Aust 2008; 189: 6-7.
14. National Cervical Screening Program: Cervical Screening in Australia 2007-2008 Data Report. Canberra, The Australian Institute of Health and Welfare and the Australian Government Department of Health and Ageing, 2010.
15. Mayrand MH, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferenczy A, Ratnam S, Coutlee F, Franco EL; Canadian Cervical Cancer Screening Trial Group: Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med 2007; 357: 1579-1588.
16. Dillner J, Rebolj M, Birembaut P, Petry KU, Szarewski A, Munk C, de Sanjose S, Naucler P, Lloveras B, Kjaer S, Cuzick J, van Ballegooijen M, Clavel C, Iftner T: Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study. BMJ 2008; 377:a1754.
17. Sankaranarayanan R, Nene BM, Shastri SS, Jayant K, Muwonge R, Budukh AM, Hingmire S, Malvi, S, Thorat R, Kothari A, Chinoy R, Kelkar R, Kane S, Desai S, Keskar VR, Rajeshwarkar R, Panse N, Dinshaw KA: HPV screening for cervical cancer in rural India. N Engl J Med 2009; 360: 1385-1394.
18. Wright TC Jr: Cervical cancer screening in the 21st century: is it time to retire the PAP smear? Clin Obstet Gynecol 2007; 50: 313-323.
19. Nanda K, McCrory DC, Myers ER, Bastian LA, Hasselblad V, Hickey JD, Matchar DB: Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med 2000; 132: 810-819.
20. Baleriola C, Millar D, Melki J, Coulston N, Altman P, Rismanto N, Rawlinson W: Comparison of a novel HPV test with the Hybrid Capture II (hcII) and a reference PCR method shows high specificity and positive predictive value for 13 high-risk human papillomavirus infections. J Clin Virol 2008; 42: 22-26.
21. Myers E, Huh WK, Wright JD, Smith JS: The current and future role of screening in the era of HPV vaccination. Gynecol Oncol 2008; 109:S31-S39.
22. Franco EL, Cuzick J, Hildesheim A, de Sanjose S: Chapter 20: issues in planning cervical cancer screening in the era of HPV vaccination. Vaccine 2006; 24:S3/171-177.
23. Davey E, Barratt A, Irwig L, Chan SF, Macaskill P, Mannes P, Saville AM: Effect of study design and quality on unsatisfactory rates, cytology classifications, and accuracy in liquid-based cytology versus conventional cervical cytology: a systematic review. Lancet 2006; 367: 122-132.
24. Davey E, d'Assuncao J, Irwig L, Macaskill P, Chan SF, Richards A, Farnsworth A: Accuracy of reading liquid based cytology slides using the ThinPrep Imager compared with conventional cytology: prosstudy. BMJ 2007; 335: 1-8.
25. Dehn D, Torkko KC, Shroyer KR: Human papillomavirus testing and molecular markers of cervical dysplasia and carcinoma. Cancer Cytopathol 2007; 111: 1-14.
26. Coquillard G, Palao B, Patterson BK: Quantification of intracellular HPV E6/E7 mRNA expression increases the specificity and positive predictive value of cervical cancer screening compared to HPV DNA. Gynecol Oncol 2011; 120: 89-93.